Zoetis (ZTS) Change in Accured Expenses (2014 - 2026)
Zoetis' (ZTS) quarterly Change in Accured Expenses came in at $142.0 million in Q2 2026, down 2.07% year-over-year from $145.0 million in Q2 2025, and up 160.68% quarter-over-quarter from -$234.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Accured Expenses for 13 consecutive years, with $142.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 2.07% year-over-year to $142.0 million in Q2 2026; TTM through Jun 2026 was $54.0 million, a 61.7% decrease from a year earlier, with the FY2025 full-year figure at $85.0 million, down 25.44% from the prior year.
- Change in Accured Expenses was $142.0 million for Q2 2026 at Zoetis, up from -$234.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $145.0 million in Q2 2025 and troughed at -$234.0 million in Q1 2026.
- A 5-year average of -$333333.3 and a median of $34.5 million in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses plunged 208.33% in 2022 and jumped 825.0% in 2024, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $47.0 million in 2022, then soared by 100.0% to $94.0 million in 2023, then retreated by 17.02% to $78.0 million in 2024, then rose by 12.82% to $88.0 million in 2025, then soared by 61.36% to $142.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $142.0 million (Q2 2026), -$234.0 million (Q1 2026), and $88.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 142.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 28.65 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.00 Mn |
| Mar 31, 2026 | -234.00 Mn |
| Dec 31, 2025 | 88.00 Mn |
| Sep 30, 2025 | 58.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | -206.00 Mn |
| Dec 31, 2024 | 78.00 Mn |
| Sep 30, 2024 | 124.00 Mn |
| Jun 30, 2024 | 37.00 Mn |
| Mar 31, 2024 | -125.00 Mn |
| Dec 31, 2023 | 94.00 Mn |
| Sep 30, 2023 | 32.00 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | -63.00 Mn |
| Dec 31, 2022 | 47.00 Mn |
| Sep 30, 2022 | -21.00 Mn |
| Jun 30, 2022 | 16.00 Mn |
| Mar 31, 2022 | -222.00 Mn |
| Dec 31, 2021 | 165.00 Mn |
| Sep 30, 2021 | 41.00 Mn |